Literature DB >> 6327119

Automated kinetic determination of angiotensin-converting enzyme in serum.

A Harjanne.   

Abstract

In this automated kinetic modification of a previous method (Anal Biochem 95: 540-548, 1979) for determining angiotensin-converting enzyme (EC 3.4.15.1), 3-(2- furylacryloyl )-L- phenylalanylglycylglycine is used as the substrate. The change in absorbance at 340 nm is used to monitor hydrolysis of the substrate. The rate of hydrolysis is roughly threefold greater than with previously reported substrates, so assay time and sensitivity are improved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327119

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Safety and tolerance of single oral doses of trandolapril (RU 44.570), a new angiotensin converting enzyme inhibitor.

Authors:  A Patat; A Surjus; A Le Go; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril.

Authors:  E G Bevan; G T McInnes; J C Aldigier; J J Conte; J P Grunfeld; S J Harper; B H Meyer; N Pauly; R Wilkinson
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

3.  Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats.

Authors:  A E Roşca; I Stoian; C Badiu; L Gaman; B O Popescu; L Iosif; R Mirica; I C Tivig; C S Stancu; C Căruntu; S E Voiculescu; L Zăgrean
Journal:  Braz J Med Biol Res       Date:  2016-05-31       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.